Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous system-Reference-Cited by-同舟云学术

Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous system

Published:2014-02-27 Issue:3 Volume:41 Page:788-796
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Gutierrez Juan E.¹,Rosenberg Martin²,Duhaney Michael³,Simon Jeffrey A.⁴,Brueggenwerth Guenther⁵,Agris Jacob M.²,Knopp Edmond A.⁶

Affiliation:

1. Neuroradiology Section; The University of Texas Health Science Center at San Antonio; Texas USA

2. Bayer Healthcare Pharmaceuticals; Montville New Jersey USA

3. St Joseph's Wayne Hospital; Paterson New Jersey USA

4. Radsource; Nashville Tennessee USA

5. Bayer Schering Pharma AG; Berlin Germany

6. Zwanger-Pesiri Radiology; Lindhurst New York USA

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Reference24 articles.

1. Central nervous system: review of clinical use of contrast media;Runge;Top Magn Reson Imaging,2001

2. Principles of contrast enhancement in the evaluation of brain diseases: an overview;Runge;J Magn Reson Imaging,1997

3. High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review;Giesel;Eur Radiol,2010

4. The role of magnetic resonance techniques in understanding and managing multiple sclerosis;Miller;Brain,1998

5. A new method to classify pathologic grades of astrocytomas based on magnetic resonance imaging appearances;Zhao;Neurol India,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity associated with gadolinium-based contrast-enhanced examinations;AIMS Biophysics;2021

2. Gadobutrol: A Review in Contrast-Enhanced MRI and MRA;Clinical Drug Investigation;2018-07-13

3. Time-Dependent Changes in the Magnetic Resonance Detection of Brain Metastases Using Single-Dose Gadobutrol;Iranian Journal of Radiology;2018-01-20

4. Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations;Investigative Radiology;2016-01

5. A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System;Magnetic Resonance in Medical Sciences;2016